GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » RPG Life Sciences Ltd (NSE:RPGLIFE) » Definitions » ROE %

RPG Life Sciences (NSE:RPGLIFE) ROE % : 36.83% (As of Dec. 2024)


View and export this data going back to 2008. Start your Free Trial

What is RPG Life Sciences ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. RPG Life Sciences's annualized net income for the quarter that ended in Dec. 2024 was ₹1,397 Mil. RPG Life Sciences's average Total Stockholders Equity over the quarter that ended in Dec. 2024 was ₹3,794 Mil. Therefore, RPG Life Sciences's annualized ROE % for the quarter that ended in Dec. 2024 was 36.83%.

The historical rank and industry rank for RPG Life Sciences's ROE % or its related term are showing as below:

NSE:RPGLIFE' s ROE % Range Over the Past 10 Years
Min: 0.8   Med: 16.29   Max: 25.69
Current: 21.78

During the past 13 years, RPG Life Sciences's highest ROE % was 25.69%. The lowest was 0.80%. And the median was 16.29%.

NSE:RPGLIFE's ROE % is ranked better than
91.43% of 957 companies
in the Drug Manufacturers industry
Industry Median: 4.91 vs NSE:RPGLIFE: 21.78

RPG Life Sciences ROE % Historical Data

The historical data trend for RPG Life Sciences's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RPG Life Sciences ROE % Chart

RPG Life Sciences Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.21 20.36 21.80 24.01 25.69

RPG Life Sciences Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.52 14.13 28.56 4.43 36.83

Competitive Comparison of RPG Life Sciences's ROE %

For the Drug Manufacturers - Specialty & Generic subindustry, RPG Life Sciences's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RPG Life Sciences's ROE % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, RPG Life Sciences's ROE % distribution charts can be found below:

* The bar in red indicates where RPG Life Sciences's ROE % falls into.


;
;

RPG Life Sciences ROE % Calculation

RPG Life Sciences's annualized ROE % for the fiscal year that ended in Mar. 2024 is calculated as

ROE %=Net Income (A: Mar. 2024 )/( (Total Stockholders Equity (A: Mar. 2023 )+Total Stockholders Equity (A: Mar. 2024 ))/ count )
=876.6/( (3076+3748.5)/ 2 )
=876.6/3412.25
=25.69 %

RPG Life Sciences's annualized ROE % for the quarter that ended in Dec. 2024 is calculated as

ROE %=Net Income (Q: Dec. 2024 )/( (Total Stockholders Equity (Q: Sep. 2024 )+Total Stockholders Equity (Q: Dec. 2024 ))/ count )
=1397.2/( (3793.8+0)/ 1 )
=1397.2/3793.8
=36.83 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2024) net income data. ROE % is displayed in the 30-year financial page.


RPG Life Sciences  (NSE:RPGLIFE) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2024 )
=Net Income/Total Stockholders Equity
=1397.2/3793.8
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(1397.2 / 6908.4)*(6908.4 / 5543.7)*(5543.7 / 3793.8)
=Net Margin %*Asset Turnover*Equity Multiplier
=20.22 %*1.2462*1.4613
=ROA %*Equity Multiplier
=25.2 %*1.4613
=36.83 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2024 )
=Net Income/Total Stockholders Equity
=1397.2/3793.8
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (1397.2 / 1875.6) * (1875.6 / 1748) * (1748 / 6908.4) * (6908.4 / 5543.7) * (5543.7 / 3793.8)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.7449 * 1.073 * 25.3 % * 1.2462 * 1.4613
=36.83 %

Note: The net income data used here is four times the quarterly (Dec. 2024) net income data. The Revenue data used here is four times the quarterly (Dec. 2024) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


RPG Life Sciences ROE % Related Terms

Thank you for viewing the detailed overview of RPG Life Sciences's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


RPG Life Sciences Business Description

Traded in Other Exchanges
Address
463, Dr. Annie Besant Road, RPG House, Near Old Passport Office, Worli, Mumbai, MH, IND, 400030
RPG Life Sciences Ltd is an integrated pharmaceutical company. Its only reportable segment is the manufacturing and marketing of pharmaceutical products. Geographically, it derives a majority of revenue from India. The company operates across Domestic Formulations, International Formulations and Active Pharmaceutical Ingredients (API). It focuses on Nephrology, Oncology, Urology, Respiratory, Gastrointestinal, Cardiovascular, Gynaecology and Pediatrics, Vitamins and Minerals, Pain Management, Neurology, Anti-Dengue, Anti-Diabetic, and Derma.

RPG Life Sciences Headlines

No Headlines